amiodarone has been researched along with Shock, Cardiogenic in 10 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone, given as a single intravenous bolus through a peripheral vein rapidly reduced ventricular rate and was well tolerated in patients with atrial fibrillation, even in the presence of congestive heart failure and cardiogenic shock." | 7.72 | Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock. ( Hofmann, R; Kammler, J; Kypta, A; Leisch, F; Steinwender, C; Wimmer, G, 2004) |
| "Amiodarone, given as a single intravenous bolus through a peripheral vein rapidly reduced ventricular rate and was well tolerated in patients with atrial fibrillation, even in the presence of congestive heart failure and cardiogenic shock." | 3.72 | Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock. ( Hofmann, R; Kammler, J; Kypta, A; Leisch, F; Steinwender, C; Wimmer, G, 2004) |
| "Giant cell myocarditis is a rare and highly lethal disease that is characterized by a rapidly progressive course of biventricular dysfunction." | 1.37 | Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis. ( Drafts, BC; Dubose, TD; Sutton, BJ; Thohan, V, 2011) |
| "Knowledge on ventricular tachycardia (VT) in isolated ventricular noncompaction (IVNC) is limited." | 1.36 | Septal ventricular tachycardia with alternating LBBB-RBBB morphology in isolated ventricular noncompaction. ( Bulková, V; Fiala, M; Januska, J; Pleva, M, 2010) |
| "Amiodarone was given initially to the other 4 patients in whom adenosine caused only temporary conversion to the sinus rhythm." | 1.36 | Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. ( Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viveiros, E | 1 |
| Aveiro, AC | 1 |
| Costa, E | 1 |
| Nunes, JL | 1 |
| Fiala, M | 1 |
| Januska, J | 1 |
| Bulková, V | 1 |
| Pleva, M | 1 |
| Dilber, E | 1 |
| Mutlu, M | 1 |
| Dilber, B | 1 |
| Aslan, Y | 1 |
| Gedik, Y | 1 |
| Celiker, A | 1 |
| Drafts, BC | 1 |
| Sutton, BJ | 1 |
| Dubose, TD | 1 |
| Thohan, V | 1 |
| Jan, SL | 1 |
| Fu, YC | 1 |
| Lin, MC | 1 |
| Hwang, B | 1 |
| Walker, GM | 1 |
| McLeod, K | 1 |
| Brown, KL | 1 |
| Franklin, O | 1 |
| Goldman, AP | 1 |
| Davis, C | 1 |
| Shinde, AA | 1 |
| Juneman, EB | 1 |
| Mitchell, B | 1 |
| Pierce, MK | 1 |
| Gaballa, MA | 1 |
| Goldman, S | 1 |
| Thai, H | 1 |
| Hofmann, R | 1 |
| Steinwender, C | 1 |
| Kammler, J | 1 |
| Kypta, A | 1 |
| Wimmer, G | 1 |
| Leisch, F | 1 |
| Chockalingam, A | 1 |
| Tejwani, L | 1 |
| Aggarwal, K | 1 |
| Dellsperger, KC | 1 |
| Shieh, JP | 1 |
| Chu, CC | 1 |
| Chen, JY | 1 |
| Chen, YH | 1 |
| Yeh, FC | 1 |
| Hsing, CH | 1 |
1 review available for amiodarone and Shock, Cardiogenic
| Article | Year |
|---|---|
Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence.
Topics: Adrenergic beta-Antagonists; Aged; Algorithms; Amiodarone; Cardiac Catheterization; Diagnosis, Diffe | 2007 |
9 other studies available for amiodarone and Shock, Cardiogenic
| Article | Year |
|---|---|
Cardiogenic shock in a neonate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Shock, | 2013 |
Septal ventricular tachycardia with alternating LBBB-RBBB morphology in isolated ventricular noncompaction.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Catheter Ablation; Echocardiogr | 2010 |
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therap | 2010 |
Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Cardiac Catheterization; | 2011 |
Precordial thump in a newborn with refractory supraventricular tachycardia and cardiovascular collapse after amiodarone administration.
Topics: Amiodarone; Bradycardia; Cardiopulmonary Resuscitation; Drug Resistance; Electrocardiography; Emerge | 2012 |
Extracorporeal life support as a treatment of supraventricular tachycardia in infants.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Extracorporeal Membrane Oxygenation; Female | 2003 |
Shocks from pacemaker cardioverter defibrillators increase with amiodarone in patients at high risk for sudden cardiac death.
Topics: Aged; Amiodarone; Case-Control Studies; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Re | 2003 |
Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiograph | 2004 |
Acute fatal vasoplegia and asystole induced by intravenous amiodarone after cardiopulmonary bypass in a patient with preoperative cardiogenic shock.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Fatal Outcome; Female; Heart Arrest; Hum | 1999 |